大人の骨格筋量に対するティルゼパチドの効果: 系統的レビュー
Roberto A Hidalgo Ramos1, Isaac Hong1, Marcelo Ortiz1
1Faculty of Medicine, University of Costa Rica, San Jose, CRI.
Cureus
|September 2, 2025
まとめ
チルゼパチドは脂肪を減らし,筋肉を保ち,体重管理に役立ちます. この体系的なレビューは,骨格筋の健康を損なうことなく,体組成に良い効果を示しています.
科学分野:
- 内分泌学
- メタボリズム
- 運動 生理学
背景:
- ティルゼパチドは体重管理のための新興治療法です.
- 骨格の筋肉と体質に及ぼす影響への関心が高まっている.
- これらの効果を理解することは 患者の総合的なケアに不可欠です
研究 の 目的:
- 骨格筋量に対するティルゼパチドの影響を体系的に検討する.
- ティルゼパチドが成人の体質に与える影響を評価する.
- ティルゼパチドと筋肉の健康に関する現在の証拠を統合する.
主な方法:
- 2025年6月26日までの4つの主要なデータベースで体系的な文献検索
- 系統的レビューとメタ分析 (PRISMA) のガイドラインの優先事項への遵守
- 成人の骨格筋または痩身質を検証したランダム化臨床試験の含有
主要な成果:
- チルゼパチドの治療は脂肪の有意な減少と関連していました.
- 治療中に体脂肪の相対的な保存が観察されました.
- 筋肉組成の指標は安定したままだったか,改善を示した.
結論:
- チルゼパチドは全身の組成を改善する可能性がある.
- この薬は骨格筋を大きく傷つけることなく効果があるようです.
- 発見を確認し,機能的影響を評価するためにさらなる研究が必要である.
関連する概念動画
Skeletal Muscle Relaxants: Adverse Effects
468
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
468
Skeletal Muscle Relaxants: Therapeutic Uses
612
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
612
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Skeletal Muscle Anatomy
89.6K
Skeletal muscle is the most abundant type of muscle in the body. Tendons are the connective tissue that attaches skeletal muscle to bones. Skeletal muscles pull on tendons, which in turn pull on bones to carry out voluntary movements.
89.6K
Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K


